Shut observation and Regular titration are warranted right up until pain management is stable on the new opioid. Observe people for symptoms and indicators of opioid withdrawal and for signs of oversedation/toxicity after converting people to OXYCONTIN.Stage #three: Shut observation and titration are warranted right until pain management is secure